Início › Câncer de Mama › Minnesota › Rochester
Ensaios clínicos de Câncer de Mama em Rochester, MN
42 estudos para Câncer de Mama estão buscando participantes em locais em Rochester e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
RecrutandoFase 2Voluntários saudáveis bem-vindos
- Mayo Clinic in Rochester, Rochester
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RecrutandoFase 2
- Mayo Clinic, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
RecrutandoFase 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Recrutando
- Mayo Clinic, Rochester
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RecrutandoFase 2
- Mayo Clinic Cancer Center, Rochester
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Recrutando
- Mayo Clinic, Rochester
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecrutandoFase 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RecrutandoFase 2
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- Mayo Clinic - Rochester, Rochester
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
RecrutandoFase 2
- Mayo Clinic, Rochester
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecrutandoFase 1/2
- Mayo Rochester, Rochester
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- Mayo Clinic, Rochester
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
RecrutandoFase 1
- Mayo Clinic, Rochester
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
RecrutandoFase 1/2
- Mayo Clinic, Rochester
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Mayo Clinic in Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecrutandoFase 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
RecrutandoFase 1
- Mayo Clinic, Rochester
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Mayo Clinic in Rochester, Rochester
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
Recrutando
- Mayo Clinic in Rochester, Rochester
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecrutandoFase 3
- Mayo Clinic in Rochester, Rochester
E-Mindfulness Approaches for Living After Breast Cancer
RecrutandoFase 3
- Mayo Clinic in Rochester, Rochester
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
RecrutandoFase 1
- Mayo Clinic in Rochester, Rochester
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RecrutandoFase 1
- Mayo Clinic Rochester, Rochester
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecrutandoFase 1/2
- Mayo Clinic - Rochester, Rochester
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RecrutandoFase 3
- Mayo Clinic - Rochester, Rochester
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
RecrutandoFase 1 inicial
- Mayo Clinic in Rochester, Rochester
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
RecrutandoFase 1
- Mayo Clinic Rochester, Rochester
3D Ultrasound Breast Imaging
Recrutando
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Recrutando
- Mayo Clinic, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecrutandoFase 2
- Mayo Clinic, Rochester
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecrutandoFase 3
- Mayo Clinic in Rochester, Rochester
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
RecrutandoFase 1/2
- Mayo Clinic, Rochester
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
RecrutandoEstudo observacional
- Mayo Clinic in Rochester, Rochester
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecrutandoFase 1/2
- Mayo Clinic, Rochester
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- Mayo Clinic, Rochester
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
RecrutandoEstudo observacional
- Mayo Clinic, Rochester
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
RecrutandoEstudo observacional
- Mayo Clinic in Rochester, Rochester
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
RecrutandoEstudo observacional
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Mayo Clinic, Rochester
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
Recrutando
- Mayo Clinic in Rochester, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #14, Rochester
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
RecrutandoFase 1
- Biotheryx Investigative Site, Rochester
Ensaios de Câncer de Mama em outras cidades
- New York City, NY134 estudos
- Houston, TX126 estudos
- Boston, MA111 estudos
- Nashville, TN80 estudos
- Los Angeles, CA72 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Durham, NC63 estudos
- Queens, NY63 estudos
- Chicago, IL58 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Rochester
- Câncer de Pulmão de Não Pequenas Células37 estudos
- Câncer Metastático31 estudos
- Câncer (todos os tipos)30 estudos
- Câncer Colorretal29 estudos
- Câncer de Ovário29 estudos
- Mieloma Múltiplo24 estudos
- Câncer de Próstata22 estudos
- Insuficiência Cardíaca22 estudos
- Câncer de Pâncreas22 estudos
- Câncer de Pulmão20 estudos
- Câncer Endometrial20 estudos
- Leucemia Linfocítica Crônica19 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.